Cadonilimab as Neoadjuvant Therapy in Resectable Stage II-III MSI-H/dMMR Colorectal Cancer

计划入组 22 人 · 首次发布于 2023 年 6 月 22 日

Different Cycles of Preoperative Neoadjuvant Sintilimab in Mismatch-repair Deficient/microsatellite Instability-high, Locally Advanced Colorectal Cancer

计划入组 96 人 · 首次发布于 2024 年 11 月 21 日

Neoadjuvant Toripalimab With or Without Celecoxib in dMMR/MSI-H Colorectal Cancer

计划入组 270 人 · 首次发布于 2019 年 4 月 24 日

antibody-based therapy (microsatellite-stable colorectal cancer)

Colorectal cancer vaccine (Oryx)

Colorectal Cancer(Envisagenics)

Austrian Breast & Colorectal Cancer Study Group

Austria

BORDEAUX COLORECTAL INSTITUTE ACADEMY

France

HIGH POINT UNIVERSITY

United States

Biocartis Receives FDA Approval for First Fully Automated Companion Diagnostic Test for Colorectal Cancer

Sensei Biotherapeutics Reports Promising Results for VISTA-Targeting Antibody in PD-L1 Resistant Tumors

FDA Grants Fast Track Designation to Nouscom's NOUS-209 for Lynch Syndrome Cancer Prevention